SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10047	Companies
204826	Keywords
135081	Articles
108598	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/19/2025 at 20:21, 2 months 29 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 3 months ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF

published on 12/17/2025 at 07:35, 3 months ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
PRESS RELEASE

published on 12/17/2025 at 07:30, 3 months ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 3 months 2 days ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 3 months 2 days ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
PRESS RELEASE

published on 12/15/2025 at 07:05, 3 months 2 days ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations
BRIEF

published on 12/15/2025 at 07:05, 3 months 2 days ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:00, 3 months 2 days ago

Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi anticipates a delay in tolebrutinib regulatory decision for nrSPMS, with ongoing discussions with the FDA. An expanded access protocol has been submitted for eligible patients

FDA Sanofi Tolebrutinib Regulatory Submission NrSPMS
BRIEF

published on 12/11/2025 at 07:05, 3 months 6 days ago

Sanofi obtains approval in China for Qfitlia and Cablivi

China Sanofi Rare Diseases Qfitlia Cablivi

Accesswire

Published on 03/17/2026 at 23:10, 44 minutes ago

Redwood AI CEO Louis Dron Featured on Conversations That Matter to Discuss AI Chemistry Platform and Broader Applications
Published on 03/17/2026 at 22:30, 1 hour 24 minutes ago

Galway Metals Appoints Red Cloud Financial Services to Provide Financial Advisory and Promotional Services
Published on 03/17/2026 at 21:30, 2 hours 24 minutes ago

Rainy Mountain Announces Appointment of Colton Griffith to Board of Directors
Published on 03/17/2026 at 21:10, 2 hours 44 minutes ago

BTU Announces Financing
Published on 03/17/2026 at 13:30, 10 hours 24 minutes ago

Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026

View all ACCESSWIRE

EQS Group

Published on 03/17/2026 at 23:43, 11 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - Daily buy back notice
Published on 03/17/2026 at 21:21, 2 hours 33 minutes ago

KION GROUP AG successfully places a bond of € 500 million
Published on 03/17/2026 at 20:55, 2 hours 58 minutes ago

EQS-Adhoc: thyssenkrupp nucera lowers its sales and EBIT outlook for the Group and the gH2 segment for FY 2025/26 due to higher project costs
Published on 03/17/2026 at 18:07, 5 hours 46 minutes ago

POS-Transaction in Own Shares
Published on 03/17/2026 at 17:58, 5 hours 56 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 03/17/2026 at 07:00, 16 hours 54 minutes ago

Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 5 hours ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 5 hours ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 5 hours ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 1 day 6 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE